Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
View Older Stories View More Recent Stories
-
Canaccord Genuity Assumes Coverage on Oasis Petroleum (OAS) at Buy; Positioning Asset Base to Accelerate Growth in 2012
-
Canaccord Genuity Assumes Coverage on Northern Oil and Gas (NOG) at Buy; Expecting Blowout H2/11 from Accelerated Bakken Activity
-
Canaccord Genuity Assumes Coverage on Magnum Hunter (MHR) at Buy; Sum of Parts Warranted Given Relative Mispricing of Assets
-
Canaccord Genuity Assumes Coverage on Approach Resources (AREX) at Buy; Meaningful Catalysts to Drive Horizontal Wolfcamp Potential
-
Canaccord Genuity on Progressive Waste Solutions (BIN): Don’t Throw This One Out
-
Canaccord Genuity Reiterates a 'Buy' on ArthroCare (ARTC); Notes From the Road
-
Canaccord Genuity Starts Anacor Pharmaceuticals (ANAC) at Buy; Late-stage Clinical Candidates Approaching Large Markets
-
Canaccord Genuity Maintains a 'Buy' on Apogee Enterprises (APOG); August Quarter Shows Improvement, Valuation Near Trough Lows
-
Canaccord Genuity Reiterates a 'Buy' on Under Armour (UA); Shop-in-Shops Add Incremental Visibility to Sales Growth
-
Canaccord Genuity Maintains a 'Buy' on Halliburton (HAL); Macondo Report Confirms Limited Blame
-
Canaccord Genuity Maintains a 'Buy' on ENSCO International (ESV); Possible Rig Downtime
-
Canaccord Genuity Reiterates a 'Buy' on Solta Medical (SLTM); LipoSonix Acquisition Positions Solta Into Fast Growing Fat Market
-
Canaccord Genuity Reiterates a 'Buy' on Qualcomm (QCOM); Healthy Smartphone Trends, QCT Share Gains Drive Growth
-
Canaccord Genuity Maintains a 'Buy' on Nuance Communications (NUAN); Still A Favorite GARP Stock
-
Canaccord Genuity Reiterates a 'Buy' on Spreadtrum Communications (SPRD); TD-SCDMA and Dual-SIM 2G Market Trends Positive
-
Canaccord Genuity on Semi Devices: Taiwan Takeaways - Reversing Cautious Stance Held Since Late May
-
Canaccord Genuity Maintains a 'Buy' on Spectranetics (SPNC); New Study Bullish for Lead Management Business
-
Canaccord Genuity Reiterates a 'Buy' on Amicus Therapeutics (FOLD); Study 012: Amigal vs. ERT First Patient Dosed; Expect Data 2014
-
Canaccord Genuity Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); DIFICID Launch Starts Strong
-
Canaccord Genuity Maintains a 'Buy' on Intersil (ISIL); Bookings on the Mend Following Unsurprising Preannouncement
-
Canaccord Genuity Maintains a 'Speculative Buy' on RealNetworks (RNWK); Updating Model and Target Price
-
Canaccord Genuity Maintains a 'Buy' on Basic Energy Services (BAS); Mid-quarter Update
-
Canaccord Genuity Maintains a 'Hold' on Quidel (QDEL); 2011/2012 Flu Season Prediction
-
Canaccord Genuity Starts Zalicus (ZLCS) at Buy; Synavive: Safer Steroid with Significant Potential in RA
-
Canaccord Genuity Maintains a 'Buy' on DigitalGlobe (DGI); Encouraged After Company Meeting
-
Canaccord Genuity Starts Zalicus (ZLCS) at Buy
-
Canaccord Genuity Morning Coffee: Treasury Secretary Tim Geithner - Words From The Forgotten Man
-
Canaccord Genuity Morning Coffee: Fed Chairman Ben Bernanke - Too Late To Go Into Acting?
-
Canaccord Genuity maintains a 'Buy' on Orthofix (OFIX); Comments From Roadshow
-
Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Generic Copaxone Trial -- Day 2
-
Canaccord Genuity Maintains a 'Buy' on Inventure Foods (SNAK); Jamba Smoothie Distribution Expansion Continues
-
Canaccord Genuity Maintains a 'Hold' on United Natural Foods (UNFI); Quality Q4, but Lowering F2012 Estimates
-
Canaccord Genuity Maintains a 'Hold' on Texas Instruments (TXN); Weak Mid-quarter in Keeping with Analog Slowdown
-
Canaccord Genuity Reiterates a 'Buy' on Descartes (DSGX); No Holes in This Quarter; Upside Revenue and EBITDA
-
Canaccord Genuity Maintains a 'Buy' on Triangle Petroleum (TPLM); Expecting Blowout H2/11 from Accelerated Bakken Activity
-
Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Generic Copaxone Suit: Strong Defendant Opening Arguments on Noninfringement
-
Canaccord Genuity Assumes Coverage on Cadence Pharma (CADX) at Buy; Now for the Hard Part: Ofirmev Sell-Through is On
-
Canaccord Genuity Reiterates a 'Buy/Best Idea' on NCI Building Systems (NCS); Impressive Results in a Challenging Economy
-
Canaccord Genuity Maintains a 'Buy' on FuelCell Energy (FCEL); Q3 Review: P&L Makes Progress
-
Canaccord Genuity Maintains a 'Hold' on EnCana Corp. (ECA); Lowering 2012 Estimates; Reiterate Trade Opportunity
-
UPDATE - Canaccord Genuity Upgraded Astec Industries (ASTE) to Buy; Recent Pullback Offers Opportunity
-
Canaccord Genuity Upgrades Astec Industries (ASTE) to Buy
-
Notable Analyst Rating Changes 09/07: (LVS) (TWX) (NDAQ) Upgraded; (DOV) (HST) (GS) Downgraded
-
Canaccord Genuity Reiterates a 'Buy' on EnteroMedics (ETRM); ReCharge Nutritional Protocol Not Restrictive; Little Impact on Control Weight Loss
-
Canaccord Genuity Reiterates a 'Buy' on Pharmasset (VRUS); HCV Treatment Bar Raised by PROTON
-
Canaccord Genuity Reiterates a 'Buy' on Horsehead Holding (ZINC); Think ZINC
-
Canaccord Genuity Maintains a 'Hold' on United Natural Foods (UNFI); Good Q4 Still Expected, Along with Some Hurricane Challenges
-
Canaccord Genuity Maintains a 'Buy' on GLG Life Tech (GLGL); Encouraging Stevia Forecasts
-
Canaccord Genuity Maintains a 'Hold' on Altera (ALTR); Cuts View as Non-Asia Business Weighs
-
Canaccord Genuity maintains a 'Hold' on Fairchild Semi (FCS); Lower Outlook Portends More Negatives from PC and Consumer
